Clinical trials sponsored by Vanderbilt-Ingram Cancer Center
8
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 1Phase 2 3Phase 4 2Not applicable 3
Conditions studied
Recruiting trials led by Vanderbilt-Ingram Cancer Center
- Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
- Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
- EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing
- Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
- Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
- Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
- Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Common questions
How many trials is Vanderbilt-Ingram Cancer Center recruiting for?
Vanderbilt-Ingram Cancer Center is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.